Review
Open access
Jul 2026
Why pharmacogenomic biomarkers for chemotherapy-induced peripheral neuropathy fail: a systematic review of genetic associations, replication, and clinical translation
Current pharmacogenomic approaches to CIPN are constrained by poor replication, population bias, and inconsistent methodology, which hinder translation into clinically actionable biomarkers, which hinder translation into clinically actionable biomarkers.
Aditya Maganti, Ishara Rankothge, Hunter Sakadales et al.
· Frontiers in Pharmacology · 1 citation